Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent

Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial

(2017) Finbar J K O'Callaghan et al.   LANCET NEUROLOGY

A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience

(2016) Madeline D. Schwarz et al.   EPILEPSY & BEHAVIOR

Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study

(2014) Raili Riikonen et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study

(2014) C. A. Westall et al.   NEUROLOGY

An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms

(2013) Choong YI Fong et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone

(2013) Shaun A. Hussain et al.   EPILEPSIA

Reversible Vigabatrin-Induced Life-Threatening Encephalopathy

(2013) Yaiza Hernández Vega et al.   JAMA Neurology

Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?

(2012) Patricia Dill et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Non-vision adverse events with vigabatrin therapy

(2011) S. D. Walker et al.   ACTA NEUROLOGICA SCANDINAVICA

The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study

(2011) Finbar J. K. O’Callaghan et al.   EPILEPSIA

Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review

(2010) Melissa J. Maguire et al.   EPILEPSIA

Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009

(2010) Anne T. Berg et al.   EPILEPSIA

Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms

(2010) Aphrodite Dracopoulos et al.   EPILEPSIA

Vigabatrin for the Treatment of Infantile Spasms: Final Report of a Randomized Trial

(2010) Roy D. Elterman et al.   JOURNAL OF CHILD NEUROLOGY

Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy

(2008) James W. Wheless et al.   EPILEPSIA

Cerebral MRI abnormalities associated with vigabatrin therapy

(2008) Phillip L. Pearl et al.   EPILEPSIA